Lirong Li1 article listing Lirong Li in Nature Communications, indexed by Paperzzz from Crossref and OSF.Zanubrutinib-rituximab followed by shortened chemoimmunotherapy as frontline treatment for mantle cell lymphoma (CHESS): a phase II trial Nature Communications